Cleared Traditional

K080171 - SANARUS INCORE ROTATIONAL CORE BIOPSY DEVICE, MODELS CB3010, CB3012

K080171 is an FDA 510(k) clearance for SANARUS INCORE ROTATIONAL CORE BIOPSY D..., manufactured by Sanarus Medical, Inc.. The device is a Class 2 Gastroenterology & Urology device with product code KNW cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K080171 · Sanarus Medical, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
42d
Days
Class 2
Risk

K080171 is an FDA 510(k) clearance for the SANARUS INCORE ROTATIONAL CORE BIOPSY DEVICE, MODELS CB3010, CB3012. Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by Sanarus Medical, Inc. (Pleasanton, US). The FDA issued a Cleared decision on March 6, 2008 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sanarus Medical, Inc. devices

FDA 510(k) Submission Details - K080171

510(k) Number K080171 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 24, 2008
Decision Date March 06, 2008
Days to Decision 42 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 131d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KNW Device Classification - Class 2, Special Controls

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 304
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K080171.
VACORA VACUUM ASSISTED BIOPSY SYSTEM
K082681 · C.R. Bard, Inc. · Oct 2008
INTACT BREAST LESION EXCISION SYSTEM WITH INTACT EXCISION XL
K081057 · Intact Medical Corporation · Jun 2008
CORAMATE/SPIROTOME SYSTEM
K080095 · Medinvents · Apr 2008
ONCONTROL BONE MARROW BIOPSY SYSTEM
K072045 · Vidacare Corporation · Oct 2007
LIGHT SABRE SPINAL ACCESS DEVICE
K071814 · Minrad, Inc. · Oct 2007
RUBICOR MAGIC BREAST BIOPSY DEVICE, MODEL 31537
K071048 · Rubicor Medical, Inc. · May 2007